Clinical Trial Update: Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer

View source ↗

Summary

Completed clinical trial evaluating the combination of Iodine-125 seed implants with LHRH agonists for locally advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Iodine-125 seed implants (Iodine-125 brachytherapy seeds)
• LHRH agonists (Luteinizing hormone-releasing hormone agonists)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Prostate Cancer | Status: COMPLETED